LONGITUDINAL NATURAL HISTORY OF PATIENTS WITH TYPE I/II HEREDITARY ANGIOEDEMA: ICATIBANT OUTCOME SURVEY DATA

被引：0
|
作者：
Maurer, M.
Caballero, T.
Aberer, W.
Zanichelli, A.
Bouillet, L.
Bygum, A.
Grumach, A.
Pommie, C.
Andresen, I.
Longhurst, H.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2017年 / 119卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P164
引用
收藏
页码：S42 / S43
页数：2
相关论文
共 50 条
  • [21] IMPROVEMENT IN HEREDITARY ANGIOEDEMA DIAGNOSIS: FINDINGS FROM THE ICATIBANT OUTCOME SURVEY
    Zanichelli, A.
    Magerl, M.
    Longhurst, H.
    Aberer, W.
    Bygum, A.
    Caballero, T.
    Bouillet, L.
    Grumach, A.
    Perrin, A.
    Andresen, I.
    Maurer, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S2 - S3
  • [22] Characterization Of Hereditary Angioedema Attacks Requiring Reinjection Of Icatibant: Findings From The Icatibant Outcome Survey
    Andresen, Irmgard
    Longhurst, Hilary J.
    Bouillet, Laurence
    Caballero, Teresa
    Zanichelli, Andrea
    Maurer, Marcus
    Grumach, Anete S.
    Bygum, Anette
    Botha, Jaco
    Aberer, Werner
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB53 - AB53
  • [23] Characterisation of hereditary angioedema attacks requiring reinjection of icatibant: findings from the icatibant outcome survey
    Aberer, W.
    Longhurst, H.
    Bouillet, L.
    Caballero, T.
    Fabien, V
    Zanichelli, A.
    Maurer, M.
    Andresen, I
    ALLERGY, 2016, 71 : 86 - 86
  • [24] Efficacy of icatibant in type I and II acquired angioedema
    Capelo, A.
    Nascimento, L.
    Silva, E.
    Chieza, C.
    Silva, W.
    Neves, R.
    ALLERGY, 2023, 78
  • [25] Gender analysis of baseline characteristics and treatment outcomes in patients (pts) with hereditary angioedema type I/II: findings from the icatibant outcomes survey
    Maurer, M.
    Caballero, T.
    Bouillet, L.
    Aberer, W.
    Grumach, A. S.
    Longhurst, H. J.
    Zanichelli, A.
    Bygum, A.
    Pommie, C.
    Andresen, I
    ALLERGY, 2017, 72 : 149 - 149
  • [26] Self-administered icatibant in a patient with hereditary angioedema type I
    Wiednig, M.
    ALLERGY, 2012, 67 : 352 - 352
  • [27] EARLY ICATIBANT TREATMENT IS ASSOCIATED WITH FASTER RESOLUTION OF HEREDITARY ANGIOEDEMA ATTACKS: REAL-WORLD DATA FROM THE ICATIBANT OUTCOME SURVEY
    Longhurst, H.
    Caballero, T.
    Zanichelli, A.
    Aberer, W.
    Fabien, V.
    Bouillet, L.
    Maurer, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A47 - A48
  • [28] Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings
    Grumach, Anete S.
    Longhurst, Hilary J.
    Aberer, Werner
    Bouillet, Laurence
    Caballero, Teresa
    Bygum, Anette
    Zanichelli, Andrea
    Botha, Jaco
    Andresen, Irmgard
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (03): : 1078 - 1080
  • [29] Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey
    Zanichelli, Andrea
    Magerl, Markus
    Longhurst, Hilary J.
    Aberer, Werner
    Caballero, Teresa
    Bouillet, Laurence
    Bygum, Anette
    Grumach, Anete S.
    Botha, Jaco
    Andresen, Irmgard
    Maurer, Marcus
    CLINICAL AND TRANSLATIONAL ALLERGY, 2018, 8
  • [30] Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
    Werner Aberer
    Marcus Maurer
    Laurence Bouillet
    Andrea Zanichelli
    Teresa Caballero
    Hilary J. Longhurst
    Amandine Perrin
    Irmgard Andresen
    Allergy, Asthma & Clinical Immunology, 13
12345